Sleep Issues in Myopathic Disorders and Muscular Dystrophies

  • Valentina Joseph
  • Joe Devasahayam
  • Munish Goyal


Myopathies and muscular dystrophies are disease inherent to muscles and have the common feature of muscle weakness. Multiple sleep disorders are associated with them. Sleep disordered breathing disorder (SRBD) is the most common sleep disorder in both myopathies and muscular dystrophies. Various different factors contributed to the development of SRBD that include diaphragmatic involvement, coexisting cardiac abnormalities, reduction in lung volumes and capacities, and airway obstruction. Other sleep disorders in these conditions include insomnia, restless legs syndrome, hypersomnolence, and parasomnias.


Muscular dystrophy Cardiomyopathy Emery-Dreifuss muscular dystrophy Limb-girdle muscular dystrophy Hypersomnia Fascioscapulohumeral muscular dystrophy Sleep-related movement disorders 


  1. 1.
    Fermin AM, Afzal U, Culebras A. Sleep in neuromuscular diseases. Sleep Med Clin. 2016;11(1):53–64. Scholar
  2. 2.
    Peppard PE, Young T, Hla KM. Increased prevalence of sleep-disorderd breathing in adults. Am J Epidemiol. 2013;177(9):1006–14.CrossRefGoogle Scholar
  3. 3.
    Arens R, Muzumdar H. Sleep, Sleep disordered breathing, and nocturnal hypoventilation in children with Neuromuscular diseases. Pediatr Respir Rev. 2010;11(1):24.CrossRefGoogle Scholar
  4. 4.
    Phillips MF, Smith PE, Carroll N, Calverley PM. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 1999;160(1):198–202.CrossRefGoogle Scholar
  5. 5.
    Aboussouan LS. Sleep-disordered breathing in neuromuscular disease. Am J Respir Crit Care Med. 2015;191(9):979–89.CrossRefGoogle Scholar
  6. 6.
    Hudgel DW, Devadatta P. Decrease in functional residual capacity during sleep in normal humans. J Appl Physiol. 1984;57:1319–22.CrossRefGoogle Scholar
  7. 7.
    Ibanez J, Raurich JM. Normal values of functional residual capacity in the sitting and supine positions. Intensive Care Med. 1982;8:173–7.CrossRefGoogle Scholar
  8. 8.
    Appleberg J, Nordahl G, Janson C. Lung volume and its correlation to nocturnal apnoea and desaturation. Respir Med. 2000;94:233–9.CrossRefGoogle Scholar
  9. 9.
    Van de Graff WB. Thoracic influence on upper airway patency. J Appl Physiol (1985). 1988;65:2124–31.CrossRefGoogle Scholar
  10. 10.
    White JE, Drinnan MJ, Smithson AJ, Griffiths CJ, Gibson GJ. Respiratory muscle activity and oxygenation during sleep in patients with muscular weakness. Eur Respir J. 1989;2:26–30.Google Scholar
  11. 11.
    Smith PE, Edwards RH, Claverly PM. Mechanisms of sleep-disordered breathing in chronic neuromuscular disease: implications for management. Q J Med. 1991;81:961–73.CrossRefGoogle Scholar
  12. 12.
    McCool FD, Tzelepis GE. Dysfunction of the diaphragm. N Engl J Med. 2012;366:932–42.CrossRefGoogle Scholar
  13. 13.
    Shahrizaila N, Kinnear WJM, Wills AJ. Respiratory involvement in inherited primary muscle conditions. J Neurol Neurosurg Psychiatry. 2006;77(10):1108–15.CrossRefGoogle Scholar
  14. 14.
    Ferrerio A, Quijano-Roy S, Piche C. Mutations of the Selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet. 2002;71(4):739–49. Scholar
  15. 15.
    Mellies U, Ragette R, Schwake C. Sleep disordered breathing and respiratory failure in acid maltase deficiency. Neurology. 2001;57(7):1290–5.CrossRefGoogle Scholar
  16. 16.
    Teixeira A, Cherin P, Similowski T. Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord. 2005;15(1):32–9. Scholar
  17. 17.
    Latronico N, Bolton C. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931–41. Scholar
  18. 18.
    Madej-Pilarczyk A, Kochanski A. Emery-Dreifuss muscular dystrophy: the most recognizable laminopathy. Folia Neuopathol. 2016;54(1):1–8.Google Scholar
  19. 19.
    Sveen M-L, Thune JJ, Keber L. Cardiac involvement in patients with Limb-Girdle Muscular Dystrophy Type 2 and Becker muscular dystrophy. Arch Neurol. 2008;65(9):1196–201. Scholar
  20. 20.
    van der Kooi AJ, Van Meegen M, Bolhuis PA. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. Am J Hum Genet. 1997;60:891–5.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Perloff JK, Stevenson WG, Weiss J. Cardiac involvement in myotonic muscular dystrophy: a prospective study of 25 patients. Am J Cardiol. 1984;54(8):1074–81. Scholar
  22. 22.
    Zhang LH, Fang LG, Cheng ZW, Fang Q. Cardiac manifestations of patients with mitochondrial disease. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37(10):892–5.PubMedGoogle Scholar
  23. 23.
    Muller-Hocker J, Schafer S, Mendel B, Lochmuller H, Pongratz D. Nemaline cardiomyopathy in a young adult: an ultraimmunohistochemical study and review of literature. Ultrastruct Pathol. 2000;24(6):407–16.CrossRefGoogle Scholar
  24. 24.
    Banwell BL, Becker LE, Jay V, et al. Cardiac manifestations of congenital fiber-type disproportion myopathy. J Child Neurol. 1999;14(2):83–7.CrossRefGoogle Scholar
  25. 25.
    Lanfranchi PA, Braghiroli A, Giannuzzi P. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99:1435–40.CrossRefGoogle Scholar
  26. 26.
    Muller C, Jones H, O’Grady G, Suzrez A, Heller J, Kishnani P. Language and speech function in children with infantile Pompe disease. J Pediatr Neurol. 2009;7:147–56.Google Scholar
  27. 27.
    Renard D, Humbertclaude V, Labauge P. Macroglossia in adult Duchenne muscular dystrophy. Acta Neurol Belg. 2010;110:288.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Khan Y, Heckmatt JZ. Obstructive apnoeas in Duchenne muscular dystrophy. Thorax. 1994;49:157–61.CrossRefGoogle Scholar
  29. 29.
    Suresh S, Wales P, Cooper DG. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in pediatricpopulation. J Paediatr Child Health. 2005;41:500–3.CrossRefGoogle Scholar
  30. 30.
    Leonardis L, Blague R, Dolenc Groselj L. Sleep and breathing disorders in myotonic dystrophy type 2. Acta Neurol Scand. 2015;132:42–8.CrossRefGoogle Scholar
  31. 31.
    Bianchi MLE, Losurdo A, Silvestri G. Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2. Sleep Breath. 2014;18:579–89. Scholar
  32. 32.
    Beetar JT, Guilmette TJ, Sparadeo FR. Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. Arch Phys Med Rehabil. 1996;77(12):1298–302.CrossRefGoogle Scholar
  33. 33.
    Hoffman AJ, Given BA, Von Eye A. Relationships among pain, fatigue, insomnia and gender in persons with lung cancer. Oncol Nurs Forum. 2007;34(4):785–92.CrossRefGoogle Scholar
  34. 34.
    Jennum P, Drewes AM, Andreasen A, Nielsen KD. Sleep and other symptoms in primary fibromyalgia and in healthy controls. J Rheumatol. 1993;20(10):1756–9.PubMedGoogle Scholar
  35. 35.
    Power JD, Perrucio AV, Badley EM. Pain as a mediator of sleep problems in arthritis and other chronic conditions. Arthritis Rheum. 2005;53(6):911–9.CrossRefGoogle Scholar
  36. 36.
    Della Marca G, Frusciante R, Vollono C, Ricci E. Pain and the alpha-sleep anomaly: a mechanism of sleep disruption in fascioscapulohumeral muscular dystrophy. Pain Med. 2013;14(4):487–97. Scholar
  37. 37.
    Bushby KM, Pollitt C, Johnson MA, Chinnery PF. Muscle pain as a prominent feature of FSHD: four illustrative case reports. Neuromuscul Disord. 1998;8(8):574–9.CrossRefGoogle Scholar
  38. 38.
    Vianello A, Bevilacqua M, Vincenti E. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne’s muscular dystrophy. Chest. 1994;105(2):445–8.CrossRefGoogle Scholar
  39. 39.
    Mendell JR, Moxley RT, Florence J. Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy. N Engl J Med. 1989;320(24):1592–7.CrossRefGoogle Scholar
  40. 40.
    Lam EM, Shepard PW, Milone M. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology. 2013;81(2):157–64. Scholar
  41. 41.
    Ekbom K, Ulfberg J. Restless legs syndrome. J Intern Med. 2009;266(5):419–31. Scholar
  42. 42.
    Salas RE, Gamaldo CE, Allen RP. Update in restless legs syndrome. Curr Opin Neurol. 2010;23(4):401–6. Scholar
  43. 43.
    Akamine RT, Grossklauss LF, Tufik S. Restless leg syndrome exacerbated by amytriptiline in a patient with Duchenne muscular dystrophy. Sleep Sci. 2014;7(3):178–80. Epub 2014 Sep 27CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Dauvilliers YA, Laberge L. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Sleep Med Rev. 2012;16(6):539–45. Epub 2012 Mar 31CrossRefPubMedGoogle Scholar
  45. 45.
    Yu H, Laberge L, Dauvilliers Y. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep. 2011;34(2):165–70.CrossRefGoogle Scholar
  46. 46.
    Schneider-Gold C, Bellenberg B, Lukas C. Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairment, depression and daytime sleepiness. PLoS One. 2015;10(6):e0130352.CrossRefGoogle Scholar
  47. 47.
    Romigi A, Albanese M, Massa R. Sleep-wake cycle and daytime sleepiness in the myotonic dystrophies. J Neurodegener Dis. 2013;2013:692026.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Chokroverty S, Bhat S, Rosen D, Farheen A. REM behavior disorder in myotonic dystrophy type 2. Neurology. 2012;78(24):2004. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Valentina Joseph
    • 1
  • Joe Devasahayam
    • 2
  • Munish Goyal
    • 3
  1. 1.Neurology and Sleep MedicineUniversity of South Dakota-Sanford School of MedicineSioux FallsUSA
  2. 2.University of MissouriColumbiaUSA
  3. 3.Department of NeurologyUniversity of MissouriColumbiaUSA

Personalised recommendations